FRX Innovations Valuation

Is FRXI.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FRXI.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FRXI.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FRXI.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FRXI.F?

Key metric: As FRXI.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for FRXI.F. This is calculated by dividing FRXI.F's market cap by their current revenue.
What is FRXI.F's PS Ratio?
PS Ratio	1x
Sales	US$3.05m
Market Cap	US$3.08m

FRXI.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.1x
Enterprise Value/EBITDA	-3.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does FRXI.F's PS Ratio compare to its peers?

The above table shows the PS ratio for FRXI.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.4x
GURE Gulf Resources	0.4x	n/a	US$6.8m
ADMT ADM Tronics Unlimited	1.7x	n/a	US$5.9m
TANH Tantech Holdings	0.03x	n/a	US$1.3m
VYST Vystar	3.6x	n/a	US$175.4k
FRXI.F FRX Innovations	1x	n/a	US$4.1m

Price-To-Sales vs Peers: FRXI.F is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (2.3x).

Price to Sales Ratio vs Industry

How does FRXI.F's PS Ratio compare vs other companies in the US Chemicals Industry?

10 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.03x	5.0%	US$117.53m
ALTO Alto Ingredients	0.1x	3.1%	US$106.54m
BON Bon Natural Life	0.2x	n/a	US$5.36m
ABLT American Biltrite	0.02x	n/a	US$2.91m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: FRXI.F is good value based on its Price-To-Sales Ratio (1x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is FRXI.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FRXI.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate FRXI.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Trinseo

US$117.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.25

-10.2%

-49.9%

Huntsman

US$3.3b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.42

-1.3%

-22.1%

CMOC Group

HK$166.5b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.77

1.7%

40.1%